Post Herpetic Neuralgia Clinical Trial
Official title:
Acupuncture (Dry-needling) as Treatment of Post-herpetic Neuralgia: A Double-blinded Randomized Clinical Trial.
Verified date | September 2020 |
Source | Odense University Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The aim of this study is to perform the first RCT investigating the possible effect of superficial dry-needling (SDN) - a special kind of acupuncture used for PHN. The participants will be divided into two groups. Group A, the intervention group will receive SDN in the area of pain. Group B, the control group will receive a sham procedure.
Status | Completed |
Enrollment | 40 |
Est. completion date | September 14, 2020 |
Est. primary completion date | September 14, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 55 Years to 75 Years |
Eligibility |
Inclusion Criteria: - Age between 50-75 years. - Pain in the dermatomal area of the previous outbreak of HZ. - Pain located to a dermatome originating from the thoracic or lumbar spine. - At least six months since the outbreak. - Understands the purpose of the study and is able to give consent. Exclusion Criteria: - A psychiatric illness affecting participation in the study. - Active cancer - Pregnancy |
Country | Name | City | State |
---|---|---|---|
Denmark | Odense University Hospital | Odense | Funen |
Lead Sponsor | Collaborator |
---|---|
Odense University Hospital |
Denmark,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Dermal pain [LEVEL OF PAIN] | Questionnaire. Visual Analogue Scale (VAS). Patients will be asked to report on their average and maximum level of pain on a scale from 0-10. | 1 month | |
Secondary | Neuropathic pain [LEVEL OF PAIN] | Neuropathic Pain Symptom inventory (NPSI), Questionnaire. NPSI consists of 12 items in total: 10 items investigates differential symptoms descriptors and 2 items evaluate spontaneous and paroxysmal spontaneous pain. The tool evaluates mean pain intensity in the last 24h in a verbal numeric scale from zero (no pain) to 10 (worst imaginable pain). Total pain intensity score may be calculated by the sum of the 10 descriptors. The descriptors are: Burning, Squeezing, Pressure, Electric Shocks, Stabbing, Provoked by brushing. Provoked by pressure, Evoked by cold stimulation, Pins and needles, Tingling. |
1 month | |
Secondary | Quality of life [QUALITY OF LIFE/ SATISFACTION] | Short Form 36 (SF-36), Questionnaire. Scoring the RAND 36-Item Health Survey is a two-step process. First, precoded numeric values are recoded per a scoring key. All items are scored so that a high score defines a more favorable health state. Each item is scored on a 0 to 100 range so that the lowest and highest possible scores are 0 and 100, respectively. Scores represent the percentage of total possible score achieved. After this, items in the same scale are averaged together to create the 8 scale scores. The eight health concepts are: physical functioning, bodily pain, role limitations due to physical health problems, role limitations due to personal or emotional problems, emotional well-being, social functioning, energy/fatigue, and general health perceptions. It also includes a single item that provides an indication of perceived change in health. |
1 month |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05496205 -
A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT01426230 -
Phase IV Study of FDA Approved, Once-Daily GRALISEā¢(Gabapentin) Tablets for the Treatment of Postherpetic Neuralgia
|
N/A | |
Terminated |
NCT01124097 -
Eslicarbazepine Acetate as Therapy in Post-Herpetic Neuralgia
|
Phase 3 | |
Recruiting |
NCT04144972 -
Closed-Loop Deep Brain Stimulation for Refractory Chronic Pain
|
N/A | |
Completed |
NCT03447756 -
Titration Study of ABX-1431
|
Phase 1 | |
Recruiting |
NCT06155487 -
A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Oral Administration of AJH-2947 in Healthy Korean and/or Caucasian Adult Male Subjects
|
Phase 1 | |
Recruiting |
NCT06218784 -
A MAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers and PHN Patients.
|
Phase 1 | |
Completed |
NCT03584061 -
Treatment of Chronic Postherpetic Pain With Fat Grafting
|
N/A | |
Completed |
NCT01270828 -
Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Postherpetic Neuralgia
|
Phase 3 | |
Enrolling by invitation |
NCT06410222 -
Predictive Models for the Treatment of Recurrent Herpes Zoster Neuralgia Following Spinal Cord Electrical Stimulation.
|
||
Recruiting |
NCT05754190 -
Assessing Symptom and Mood Dynamics in Pain Using the Smartphone Application SOMA
|
||
Completed |
NCT00475904 -
A Comparison of EpiCeptā¢ NP-1 Topical Cream vs. Oral Gabapentin in Postherpetic Neuralgia (PHN)
|
Phase 2 | |
Completed |
NCT03765697 -
A Study With Lidocaine 5% Medicated Plaster in Patients Suffering From Postherpetic Neuralgia
|
Phase 3 | |
Not yet recruiting |
NCT06130514 -
The Comparison of Sympathetic Blockade of Stellate Ganglion Block and Thoracic Sympathetic Ganglion Block
|
N/A | |
Completed |
NCT01748877 -
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
|
Phase 2 | |
Active, not recruiting |
NCT06241820 -
The Success of Lumbar Sympathetic Ganglion Block Using Lower Extremity Perfusion Index
|
N/A | |
Completed |
NCT03745404 -
A Study With Lido-Patch and Placebo Plaster in Patients Suffering From Postherpetic Neuralgia (PHN)
|
Phase 3 |